More Than 50 Percent of Surveyed Orthopedic Surgeons and 70 Percent of Surveyed MCO Pharmacy Directors Chose Sanofi-Aventis's Lovenox as the Most Effective Anticoagulant for VTE Primary Prophylaxis, When Compared to Other Av